Answers are grounded in this paper and cite their sources.
Although missing data weaken interpretation of the findings, administration of goserelin with chemotherapy appeared to protect against ovarian failure, reducing the risk of early menopause and improving prospects for fertility. (Funded by the National Cancer Institute and others; POEMS/S0230 ClinicalTrials.gov number, NCT00068601.).
No takes yet. Share an insight, caveat, or question.
Moore et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: